U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Method for treating canine distemper

Patent 5807840 Issued on September 15, 1998. Estimated Expiration Date: Icon_subject November 4, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Inventor

Assignee

Application

No. 963849 filed on 11/04/1997

US Classes:

514/44, Polynucleotide (e.g., RNA, DNA, etc.)424/1.17, Attached to or within viable or inviable whole micro-organism, cell, virus, fungus or specified sub-cellular structure thereof (e.g., platelet, red blood cell)424/1.73, Attached to carbohydrate compound; derivative thereof (e.g., DNA, nucleotide, nucleoside, sugar, starch, tannin, saccharide, polysaccharide, cellulose, O-, N- and S-glycoside, vitamin B12)424/159.1, Binds virus or component thereof424/211.1, Paramyxoviridae (e.g., parainfluenza virus, respiratory syncytial virus, rinderpest virus, Sendai virus, canine tracheobronchitis virus, turkey rhinotracheitis virus, etc.)424/213.1, Canine distemper virus514/868DISTEMPER

Examiners

Primary: Wilson, James O.

Attorney, Agent or Firm

International Class

A61K 031/70

Abstract

The present invention discloses a method for treating patients having the CDV associated symptoms or animals carrying or infected by the canine distemper virus (CDV) or having antibodies against the CDV using Product R, a peptide-nucleic acid preparation.

Other References

  • Reynolds, Margaret R., Generalized Vaccinia, Symposium, pp. 5-6, 1960
  • Kuckku, Morris E., Herpetic Diseases, Symposium, pp. 7-13, 1960
  • Schaeffer, Oden A., Influenza, Symposium, pp. 15-21, 1960
  • Seydel, Frank, Epidemic, Asian Influenza, Symposium, pp. 23-24 1960
  • Cooke, Stanford B., Upper Respiratory Viral Manifestations, Clinical Symposium on Viral Diseases Demonstrating the Anti-viral Biotic Properties of the Drug Reticulose (Symposium), Sep., 1960, Miami Beach, Fla., pp. 25-32
  • Medoff, Lawrence R.r., Infectious Mononucleosis, Symposium, pp. 33-37, 1960
  • Anderson, Robert H., Encephalitis, Symposium, pp. 39-52, 1960
  • Plucinski, Stanisloff J., Suspected Viral Varieties, Symposium, pp. 53-59, 1960
  • Anderson, Robert H. and Thompson, Ralph M., Treatment of Viral Syndrome with a Lipoprotein-Nucleic Acid Compound (Reticulose), A Report of Five Cases, Virginia Medical Monthly, 84:347-353, 1957
  • Reynolds, Margaret R., Generalized Vaccinia Successfully Treated With Lipoprotein-Nucleic Acid Complex (Reticulose), Archives of Pediatrics, 77:421-422, 1960
  • Wegryn, Stanley P. Marks, Robert A. and Baugh, John R., Herpes Gestationis, A Report of 2 Cases, American Journal of Obstetrics and Gynecology, 79:812-814, 1960
  • Catterall, R.A., Lumpur, Kuala, A New Treatment of Herpes Zoster, Vaccinia And Chicken Pox, J. Roy, Coll. Gen. Practit., 1970, 19, 182
  • Chinnici, Angelo A., Reticulose in Treatment Aids patients, Personal Communication to William Bregman, Jul. 6, 1992
  • Cott, Rafael A., Summary of 11 Cases of Viral Infections Treated with Reticulose, Private Communication with Advance Viral Research Corp., 1989
  • Cohen, Matthew, The Efficacy of a Peptide-Nucleic Acid Solution (Reticulose) for the Treatment of Hepatitis A and Hepatitis B -a Preliminary Controlled Human Clinical Trial, J. Roy. Soc. Health, Dec., 1992, 266-270
  • Mundschenk, David D., In Vitro Antiviral Activity of Reticulose vs Influenaz A, Personal Communication with William Bregman, May 1, 1990
  • Resnick, Lionel, Anti-HIV in Vitro Activity of Two Samples of Peptide-nucleic Acid Solution, Personal Communication with Dr. Bernard Friedland, Dec. 22, 1989
  • Friedland, Bernard, In Vitro Antiviral Activity of a Peptide-Nucleic Acid Solution Against the Human Immunodeficiency Virus and Influenza A Virus, J. Roy. Soc. Health, Oct. 1991, 170-171
  • Brazier, Anne D., Method for in Vitro Antiviral Evaluation Human Immunodeficiency Virus (HIV), Personal Communication with Dr. Bernard Friedland, Oct. 4, 1989
  • Behbehani, Abbas M., Haberman Sol and Race, George J, The Effect of Reticulose on Viral Infections of Experimental Animals, Southern Medical Journal, Feb., 1962, 185-188
  • Treatment of Viral Diseases with A Lipo-protein Nucleic Acid Complex (Reticulose) -A Clinical Study, Scientific Exhibit: Virginia State Medical Society Meeting, Washington D.C., Nov., 1957
  • Kempe, Henry C., Fulginiti, Vincent A., and Vincent, Leone St., Failure to Demonstrate Antiviral Activity of Reticulose, Diseases of Children, vol. 103, No. 5, 655-657, 1962
  • Sanders, Murray, Controlled Animal Studies with Reticulose Illustrating the Interference of Lipoprotein-Nucleic Acid Complex in the Experimental Animal Infected with Human Pathogenic Viral Entities, Southern Medical Association Scientific Exhibit, Dallas, Texas, Nov., 196
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
PatentsPlus: add to cart
PatentsPlus: add to cartIntelligent turbocharged patent PDFs with marked up images
$18.95more info
 
Sign InRegister
Username  
Password   
forgot password?